| No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
| 1 |
rs17148231 |
chr7:105094664-105094665 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
| 2 |
rs555338078 |
chr7:105094692-105094693 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 3 |
rs75484204 |
chr7:105094697-105094698 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 4 |
rs116290568 |
chr7:105094763-105094764 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 5 |
rs552756928 |
chr7:105094836-105094837 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 6 |
rs557785958 |
chr7:105094852-105094853 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 7 |
rs578141256 |
chr7:105094875-105094876 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 8 |
rs372619212 |
chr7:105094909-105094910 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 9 |
rs6972417 |
chr7:105094933-105094934 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
| 10 |
rs545912193 |
chr7:105094942-105094943 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 11 |
rs558194536 |
chr7:105094958-105094959 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 12 |
rs60616177 |
chr7:105095109-105095110 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 13 |
rs141787059 |
chr7:105095113-105095114 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 14 |
rs541884879 |
chr7:105095140-105095141 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 15 |
rs369366846 |
chr7:105095145-105095146 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 16 |
rs189024018 |
chr7:105095167-105095168 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 17 |
rs576390497 |
chr7:105095173-105095174 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 18 |
rs181084903 |
chr7:105095209-105095210 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 19 |
rs185615475 |
chr7:105095258-105095259 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 20 |
rs562288473 |
chr7:105095263-105095264 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 21 |
rs190701980 |
chr7:105095279-105095280 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 22 |
rs147086540 |
chr7:105095307-105095308 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 23 |
rs140002382 |
chr7:105095322-105095323 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 24 |
rs367587340 |
chr7:105095327-105095328 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 25 |
rs546456524 |
chr7:105095514-105095515 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 26 |
rs566804449 |
chr7:105095518-105095519 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 27 |
rs535376795 |
chr7:105095569-105095570 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 28 |
rs528080779 |
chr7:105095574-105095575 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 29 |
rs548825266 |
chr7:105095636-105095637 |
Weak transcription Flanking Active TSS Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 30 |
rs75213304 |
chr7:105095637-105095638 |
Weak transcription Flanking Active TSS Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 31 |
rs77404250 |
chr7:105095658-105095659 |
Weak transcription Flanking Active TSS Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 32 |
rs76557474 |
chr7:105095659-105095660 |
Weak transcription Flanking Active TSS Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 33 |
rs78774915 |
chr7:105095660-105095661 |
Weak transcription Flanking Active TSS Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 34 |
rs75401442 |
chr7:105095661-105095662 |
Weak transcription Flanking Active TSS Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 35 |
rs112216965 |
chr7:105095699-105095700 |
Weak transcription Flanking Active TSS Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 36 |
rs11773001 |
chr7:105095708-105095709 |
Weak transcription Flanking Active TSS Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 37 |
rs557847502 |
chr7:105095752-105095753 |
Weak transcription Flanking Active TSS Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 38 |
rs529624900 |
chr7:105095797-105095798 |
Weak transcription Flanking Active TSS Enhancers Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
| 39 |
rs578023829 |
chr7:105095800-105095801 |
Weak transcription Flanking Active TSS Enhancers Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
| 40 |
rs546597484 |
chr7:105095803-105095804 |
Weak transcription Enhancers Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
| 41 |
rs375170094 |
chr7:105095804-105095805 |
Weak transcription Enhancers Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
| 42 |
rs10278911 |
chr7:105095815-105095816 |
Weak transcription Enhancers Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
| 43 |
rs554060926 |
chr7:105095830-105095831 |
Weak transcription Enhancers Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
| 44 |
rs138775322 |
chr7:105095835-105095836 |
Weak transcription Enhancers Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
| 45 |
rs557092767 |
chr7:105095878-105095879 |
Weak transcription Enhancers Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
| 46 |
rs543345203 |
chr7:105095879-105095880 |
Weak transcription Enhancers Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
| 47 |
rs563146466 |
chr7:105095882-105095883 |
Weak transcription Enhancers Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
| 48 |
rs575327479 |
chr7:105095897-105095898 |
Weak transcription Enhancers Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
| 49 |
rs544210511 |
chr7:105095904-105095905 |
Weak transcription Enhancers Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
| 50 |
rs59070916 |
chr7:105096001-105096002 |
Weak transcription Enhancers Strong transcription Genic enhancers
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|